Archives

by in
Entry Author Date Location
Alnylam Responds to Tekmira Suit 04/06/11 Boston
AVI Biopharma Adds $30M 04/01/11 Seattle
RXi Buys Apthera, Names New CEO 03/31/11 Boston
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
Who’s Going to Pay for Future Drug Development? (Part 1) 03/22/11 National
Alnylam CEO: Tekmira Accusation of Trade Secret Misuse was a “Big Surprise” 03/18/11 Boston
Tekmira Sues Alnylam, Alan Aderem Bolts to Seattle BioMed, Dendreon’s Warhorse Retires, & More Seattle-Area Life Sciences News 03/17/11 Seattle
Tekmira Sues Alnylam for $1 Billion, Accusing Partner of Misusing RNAi Trade Secrets 03/16/11 Boston
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up 03/04/11 Seattle
Marina Biotech Nabs $5.1M 02/10/11 Seattle
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars 01/28/11 National
EyeGate Adds $6M to Series D 01/06/11 Boston
Alnylam Lays Out 2015 Goals 01/06/11 Boston
AVI Partners With Karolinska 01/05/11 Seattle
Santaris Gets $14M From Pfizer 01/04/11 San Diego
How Michael French, a Military Brat Turned Dealmaker, Kept Marina Biotech Alive 12/20/10 Seattle
AVI Names New CEO 12/13/10 Seattle
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News 12/10/10 Boston
Alnylam CEO John Maraganore On Corporate Near-Termism, and Restoring Faith in RNAi 12/06/10 Boston
NanoBio Nabs $6M from Gates Foundation for Nasal Spray Vaccine 11/30/10 Detroit
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Roche Cuts to Hit Hundreds of Genentech Workers; Scientific Staff is Spared 11/17/10 San Francisco
Roche Dumps RNAi, Sends Shock Waves Through Alnylam, Tekmira 11/17/10 National
Marina Biotech Adds $3.3M 11/08/10 Seattle
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker 10/18/10 San Francisco
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer 10/14/10 Boston
La Jolla Institute Nabs $12.6M RNAi Grant 10/08/10 San Diego
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D 10/05/10 Boston
Alnylam Cuts 25-30% of Workforce, As Novartis Alliance Ends 09/23/10 Boston
Page 3 of 7 « previous page · next page »